Replies to post #2454 on Bausch Health Companies Inc (BHC)

[sirbutterknife]

I agree. Facts are facts. The stock is down over 90% from its high. The pace of decline has accelerated to 5% a week(on a good week). Follow the trend, it points downward. Keep in mind, very few stocks ever recover from this kind of beat down. Shareholders lose everything. Certain cyclical stocks, commodity stocks like U.S Steel for instance, can recover from large percentage losses. The pharmaceutical industry is not cyclical, it's highly competitive, and poorly run companies do not survive.

[DownWithPumpers]

> LIQUIDATION VALUE IS OVER 40-45 BILLION.

Then the stock is fairly valued at its current level, with its 30+ billion in debt.

Unless there's some improvement, rising asset values, or substantial earnings, you've basically described why this is a 20 dollar stock.

> SOONER OR LATER VALUE WILL WIN THE RACE

Nothing you said implies that there's any value, that outweighs the debt, in Valeant.